Bio-Techne (TECH) Operating Expenses (2009 - 2026)
Bio-Techne (TECH) posted quarterly Operating Expenses of $132.8 million for Q1 2026, down 24.48% year-over-year from $175.8 million in Q1 2025, and down 2.94% quarter-over-quarter from $136.8 million in Q4 2025.
Bio-Techne (TECH) Operating Expenses (2009 - 2026) Analysis & Trends
Bio-Techne's Operating Expenses history runs 18 years deep, the most recent figure standing at $132.8 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 24.48% year-over-year to $132.8 million; the TTM figure through Mar 2026 stood at $632.7 million (up 1.58% YoY), while the FY2025 annual figure was $688.0 million, up 22.2% from the prior year.
- Operating Expenses for Q1 2026 stood at $132.8 million, down from $136.8 million in the prior quarter.
- The five-year high for Operating Expenses was $222.7 million in Q2 2025, with the low at $110.2 million in Q2 2023.
- The 5-year median for Operating Expenses is $136.8 million (2025), against an average of $139.0 million.
- The sharpest annual moves came in 2024 and 2026: Operating Expenses soared 42.98% in 2024, then dropped 24.48% in 2026.
- Bio-Techne's Operating Expenses stood at $115.5 million in 2022, then gained by 20.02% to $138.6 million in 2023, then climbed by 5.69% to $146.5 million in 2024, then slipped by 6.59% to $136.8 million in 2025, then fell by 2.94% to $132.8 million in 2026.
- Business Quant data shows TECH's Operating Expenses at $132.8 million in Q1 2026, $136.8 million in Q4 2025, and $140.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 132.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.79 Mn |
| Dec 31, 2025 | 136.82 Mn |
| Sep 30, 2025 | 140.45 Mn |
| Jun 30, 2025 | 222.67 Mn |
| Mar 31, 2025 | 175.85 Mn |
| Dec 31, 2024 | 146.47 Mn |
| Sep 30, 2024 | 143.03 Mn |
| Jun 30, 2024 | 157.53 Mn |
| Mar 31, 2024 | 137.60 Mn |
| Dec 31, 2023 | 138.58 Mn |
| Sep 30, 2023 | 129.33 Mn |
| Jun 30, 2023 | 110.17 Mn |
| Mar 31, 2023 | 121.95 Mn |
| Dec 31, 2022 | 115.47 Mn |
| Sep 30, 2022 | 123.28 Mn |
| Jun 30, 2022 | 119.78 Mn |
| Mar 31, 2022 | 111.01 Mn |
| Dec 31, 2021 | 121.34 Mn |
| Sep 30, 2021 | 107.78 Mn |
| Jun 30, 2021 | 107.36 Mn |